With the President’s Emergency Plan For AIDS Relief poised to continue to expand the numbers of people being treated for HIV worldwide, while “transitioning” from providing services and supplies to countries confronting HIV to providing guidance and support to those countries’ efforts, a new report from the United States Government Accountability Office on PEPFAR says […]
A third in a series of reports examining components of treatment provided through the President’s Emergency Plan For AIDS Relief details how the the program has strengthened and streamlined antiretroviral drug supply planning, procuring and tracking, but also reveals a wide range of weaknesses hindering partner country management of the lifesaving medicines. The United States […]
The second of two reports from the U.S. Government Accountability Office reviewing HIV treatment efforts suppported by the President’s Emergency Plan For AIDS Relief concludes that incomplete information on the results of those efforts will interfere with accurately evaluating partner countries’ abilities to sustain treatment programs. The GAO also has produced a report on PEPFAR […]
With the groundwork for treatment provided through the President’s Emergency Plan For AIDS Relief having been laid in the first expensive years of country programs, with the purchases of generic antiretroviral drugs, and with economies of scale as the numbers of people enrolled in treatment increased, PEPFAR has reduced per patient treatment costs in recent […]
HIV
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]